FDA July 2026 Peptide Meeting: What Patients Need to Know About Access, Approval, and Safety Meto blog The FDA's Decision to Ban Compounds: What You Need to Know Are Peptides coming off of the FDA Category 2 list? A legal breakdown Holt Law Revance and TEOXANE Labs Get FDA Approval for RHA Dynamic Volume Revance posted on the topic LinkedIn Not all peptides are restricted. Here's the breakdown you actually need. The FDA's Category 2 classification affects specific compounded peptides BPC 157, TB 500, CJC 1295 Ipamorelin, AOD 9604, Epithalon, Selank, Semax. Others like Sermorelin